Recurrent miscarriage and cervical human papillomavirus infection

American Journal of Reproductive Immunology

Volumn 70, Issue 5, 2013, Pages 343-346

  Ticconi, Carlo ^a   Pietropolli, Adalgisa ^a   Fabbri, Guido ^a   Capogna, Maria Vittoria ^a   Perno, Carlo Federico ^a   Piccione, Emilio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Cervical infection; Human papillomavirus; Recurrent miscarriage

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETUS WEIGHT; GESTATIONAL AGE; HIGH RISK PATIENT; HISTOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 73; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RECURRENT ABORTION; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION; UTERINE CERVICITIS; WART VIRUS;

CERVICAL INFECTION; HUMAN PAPILLOMAVIRUS; RECURRENT MISCARRIAGE;

ABORTION, HABITUAL; ADULT; CASE-CONTROL STUDIES; CERVIX UTERI; DNA PROBES, HPV; DNA, VIRAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ITALY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREGNANCY; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 84885469491     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12156     Document Type: Article

References (12)

1. Practice Committee of the American Society for Reproductive Medicine (ASRM): Definition of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril 2013; 99:63.
2. Jauniaux E, Farquharson RG, Christiansen OB, Exalto N: Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod 2006; 21:2216-2222.
3. Matthiesen L, Kalkunte S, Sharma S: Multiple pregnancy failures: an immunological paradigm. Am J Reprod Immunol 2012; 67:334-340.
4. Hermonat PL, Kechelava S, Lowery CL, Korourian S: Trophoblasts are the preferential target for human papilloma virus infection in spontaneously aborted products of conception. Hum Pathol 1998; 29:170-174.
5. Matovina M, Husnjak K, Milutin N, Ciglar S, Grce M: Possible role of bacterial and viral infections in miscarriages. Fertil Steril 2004; 81:662-669.
6. Skoczyński M, Goździcka-Józefiak A, Kwaśniewska A: Prevalence of human papillomavirus in spontaneously aborted products of conception. Acta Obstet Gynecol Scand 2011; 90:1402-1405.
7. Ticconi C, Giuliani E, Veglia M, Pietropolli A, Piccione E, Di Simone N: Thyroid autoimmunity and recurrent miscarriage. Am J Reprod Immunol 2011; 66:452-459.
8. Masini S, Ticconi C, Gravina P, Tomassini M, Pietropolli A, Forte V, Federici G, Piccione E, Bernardini S: Thrombin-activable fibrinolysis inhibitor polymorphisms and recurrent pregnancy loss. Fertil Steril 2009; 93:694-702.
9. Ascone C, Criscuolo AA, Marcuccilli F, Ciccozzi M, Sesti F, Piccione E, Perno CF: Human papillomavirus molecular testing in women with low grade cervical lesions: experience from an italian hospital. Anticancer Res 2012; 32:1253-1258.
10. Venturoli S, Cricca M, Bonvicini F, Giosa F, Pulvirenti FR, Galli C, Musiani M, Zerbini M: HPV DNA testing by PCR-ELISA and hybrid capture II from a single cytological specimen: concordance and correlation with cytological results. J Clin Virol 2002; 25:177-185.
11. Rombaldi RL, Serafini EP, Mandelli J, Zimmermann E, Losquiavo KP: Transplacental transmission of Human Papillomavirus. Virol J. 2008; 5:106-120.
12. Agarossi A, Ferrazzi E, Parazzini F, Perno CF, Ghisoni L: Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. J Med Virol 2009; 81:529-535.